 | • レポートコード：MRC2-11QY00038 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、152ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はセリアック治療薬のグローバル市場について調査・分析したレポートです。種類別（一次治療、二次治療）市場規模、用途別（男性、女性、子供）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別セリアック治療薬の競争状況、市場シェア ・世界のセリアック治療薬市場：種類別市場規模 2015年-2020年（一次治療、二次治療） ・世界のセリアック治療薬市場：種類別市場規模予測 2021年-2026年（一次治療、二次治療） ・世界のセリアック治療薬市場：用途別市場規模 2015年-2020年（男性、女性、子供） ・世界のセリアック治療薬市場：用途別市場規模予測 2021年-2026年（男性、女性、子供） ・北米のセリアック治療薬市場分析：米国、カナダ ・ヨーロッパのセリアック治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのセリアック治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のセリアック治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのセリアック治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：ADMA Biologics、Amgen、Anthera Pharmaceuticals、Bayer、Biogen、BioLineRx、Biotest、Bristol-Myers Squibb、Celgene、Celimmune、F Hoffmann-La Roche、ImmunogenX、Immunomedics、ImmusanT、Innovate Biopharmaceuticals、Johnson & Johnson、Kedrion Biopharma、LFB Group、Merck、Novartis ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Celiac disease, also known as celiac sprue or gluten-sensitive enteropathy, is a genetic autoimmune disorder caused due to the body’s inability to process gluten that causes damage to the small intestine. Gluten, a protein found in wheat, barley, and rye, can damage the lining of the small intestine which makes it difficult for the body to absorb nutrients such as iron, fat, calcium, and folate. The immune system mistakes substances inside gluten to be a threat to the body and attacks them, in turn, causing damage to the bowel surface and hampering the body’s ability to absorb nutrition. Digestion problems, dermatitis herpetiformis, abdominal pain, weight loss, musculoskeletal problems, aphthous ulcers, iron deficiency, stunted growth, tingling sensation in the leg, and missed menstrual cycles are some of the symptoms of celiac disease. The disease can lead to various complications and health problems such as miscarriage or infertility, intestinal cancer, osteoporosis, seizures, gall bladder malfunction, neurological manifestation of the disease, stunted growth in children, and birth defects. Celiac disease can also lead to various autoimmune diseases such as lupus, thyroid disease, Sjögren’s syndrome, type 1 diabetes, and rheumatoid arthritis. It is difficult to diagnose celiac disease in the initial stages as its symptoms are similar to those of other diseases. Various sensitive and selective blood tests such as anti-tissue transglutaminase antibodies with or without IgA level and IgA anti-endomysial antibodies are used to screen the disease.
North America dominates the global market for celiac drugs due to rising incidence of celiac disease and lack of treatment options in the region. Asia is expected to show high growth rates in the next five years in global celiac drugs market, with China and India being the fastest growing markets in the Asia-Pacific region. The key driving forces for the celiac drugs market in developing countries are the large pool of patients, increasing awareness about the disease, and rising government funding in the region.
Market Analysis and Insights: Global Celiac Drugs Market
The global Celiac Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Celiac Drugs Scope and Market Size
Celiac Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Celiac Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Celiac Drugs market is segmented into
First Line Of Treatment
Second Line Of Treatment
Segment by Application, the Celiac Drugs market is segmented into
Men
Women
Children
Regional and Country-level Analysis
The Celiac Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Celiac Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Celiac Drugs Market Share Analysis
Celiac Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Celiac Drugs business, the date to enter into the Celiac Drugs market, Celiac Drugs product introduction, recent developments, etc.
The major vendors covered:
ADMA Biologics
Amgen
Anthera Pharmaceuticals
Bayer
Biogen
BioLineRx
Biotest
Bristol-Myers Squibb
Celgene
Celimmune
F Hoffmann-La Roche
ImmunogenX
Immunomedics
ImmusanT
Innovate Biopharmaceuticals
Johnson & Johnson
Kedrion Biopharma
LFB Group
Merck
Novartis
1 Study Coverage
1.1 Celiac Drugs Product Introduction
1.2 Market Segments
1.3 Key Celiac Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Celiac Drugs Market Size Growth Rate by Type
1.4.2 First Line Of Treatment
1.4.3 Second Line Of Treatment
1.5 Market by Application
1.5.1 Global Celiac Drugs Market Size Growth Rate by Application
1.5.2 Men
1.5.3 Women
1.5.4 Children
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Celiac Drugs Market Size, Estimates and Forecasts
2.1.1 Global Celiac Drugs Revenue 2015-2026
2.1.2 Global Celiac Drugs Sales 2015-2026
2.2 Global Celiac Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Celiac Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Celiac Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Celiac Drugs Competitor Landscape by Players
3.1 Celiac Drugs Sales by Manufacturers
3.1.1 Celiac Drugs Sales by Manufacturers (2015-2020)
3.1.2 Celiac Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Celiac Drugs Revenue by Manufacturers
3.2.1 Celiac Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Celiac Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Celiac Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Celiac Drugs Revenue in 2019
3.2.5 Global Celiac Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Celiac Drugs Price by Manufacturers
3.4 Celiac Drugs Manufacturing Base Distribution, Product Types
3.4.1 Celiac Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Celiac Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Celiac Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Celiac Drugs Market Size by Type (2015-2020)
4.1.1 Global Celiac Drugs Sales by Type (2015-2020)
4.1.2 Global Celiac Drugs Revenue by Type (2015-2020)
4.1.3 Celiac Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Celiac Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Celiac Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Celiac Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Celiac Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Celiac Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Celiac Drugs Market Size by Application (2015-2020)
5.1.1 Global Celiac Drugs Sales by Application (2015-2020)
5.1.2 Global Celiac Drugs Revenue by Application (2015-2020)
5.1.3 Celiac Drugs Price by Application (2015-2020)
5.2 Celiac Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Celiac Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Celiac Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Celiac Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Celiac Drugs by Country
6.1.1 North America Celiac Drugs Sales by Country
6.1.2 North America Celiac Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Celiac Drugs Market Facts & Figures by Type
6.3 North America Celiac Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Celiac Drugs by Country
7.1.1 Europe Celiac Drugs Sales by Country
7.1.2 Europe Celiac Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Celiac Drugs Market Facts & Figures by Type
7.3 Europe Celiac Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Celiac Drugs by Region
8.1.1 Asia Pacific Celiac Drugs Sales by Region
8.1.2 Asia Pacific Celiac Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Celiac Drugs Market Facts & Figures by Type
8.3 Asia Pacific Celiac Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Celiac Drugs by Country
9.1.1 Latin America Celiac Drugs Sales by Country
9.1.2 Latin America Celiac Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Celiac Drugs Market Facts & Figures by Type
9.3 Central & South America Celiac Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Celiac Drugs by Country
10.1.1 Middle East and Africa Celiac Drugs Sales by Country
10.1.2 Middle East and Africa Celiac Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Celiac Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Celiac Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 ADMA Biologics
11.1.1 ADMA Biologics Corporation Information
11.1.2 ADMA Biologics Description and Business Overview
11.1.3 ADMA Biologics Sales, Revenue and Gross Margin (2015-2020)
11.1.4 ADMA Biologics Celiac Drugs Products Offered
11.1.5 ADMA Biologics Related Developments
11.2 Amgen
11.2.1 Amgen Corporation Information
11.2.2 Amgen Description and Business Overview
11.2.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Amgen Celiac Drugs Products Offered
11.2.5 Amgen Related Developments
11.3 Anthera Pharmaceuticals
11.3.1 Anthera Pharmaceuticals Corporation Information
11.3.2 Anthera Pharmaceuticals Description and Business Overview
11.3.3 Anthera Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Anthera Pharmaceuticals Celiac Drugs Products Offered
11.3.5 Anthera Pharmaceuticals Related Developments
11.4 Bayer
11.4.1 Bayer Corporation Information
11.4.2 Bayer Description and Business Overview
11.4.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Bayer Celiac Drugs Products Offered
11.4.5 Bayer Related Developments
11.5 Biogen
11.5.1 Biogen Corporation Information
11.5.2 Biogen Description and Business Overview
11.5.3 Biogen Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Biogen Celiac Drugs Products Offered
11.5.5 Biogen Related Developments
11.6 BioLineRx
11.6.1 BioLineRx Corporation Information
11.6.2 BioLineRx Description and Business Overview
11.6.3 BioLineRx Sales, Revenue and Gross Margin (2015-2020)
11.6.4 BioLineRx Celiac Drugs Products Offered
11.6.5 BioLineRx Related Developments
11.7 Biotest
11.7.1 Biotest Corporation Information
11.7.2 Biotest Description and Business Overview
11.7.3 Biotest Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Biotest Celiac Drugs Products Offered
11.7.5 Biotest Related Developments
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Corporation Information
11.8.2 Bristol-Myers Squibb Description and Business Overview
11.8.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Bristol-Myers Squibb Celiac Drugs Products Offered
11.8.5 Bristol-Myers Squibb Related Developments
11.9 Celgene
11.9.1 Celgene Corporation Information
11.9.2 Celgene Description and Business Overview
11.9.3 Celgene Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Celgene Celiac Drugs Products Offered
11.9.5 Celgene Related Developments
11.10 Celimmune
11.10.1 Celimmune Corporation Information
11.10.2 Celimmune Description and Business Overview
11.10.3 Celimmune Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Celimmune Celiac Drugs Products Offered
11.10.5 Celimmune Related Developments
11.1 ADMA Biologics
11.1.1 ADMA Biologics Corporation Information
11.1.2 ADMA Biologics Description and Business Overview
11.1.3 ADMA Biologics Sales, Revenue and Gross Margin (2015-2020)
11.1.4 ADMA Biologics Celiac Drugs Products Offered
11.1.5 ADMA Biologics Related Developments
11.12 ImmunogenX
11.12.1 ImmunogenX Corporation Information
11.12.2 ImmunogenX Description and Business Overview
11.12.3 ImmunogenX Sales, Revenue and Gross Margin (2015-2020)
11.12.4 ImmunogenX Products Offered
11.12.5 ImmunogenX Related Developments
11.13 Immunomedics
11.13.1 Immunomedics Corporation Information
11.13.2 Immunomedics Description and Business Overview
11.13.3 Immunomedics Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Immunomedics Products Offered
11.13.5 Immunomedics Related Developments
11.14 ImmusanT
11.14.1 ImmusanT Corporation Information
11.14.2 ImmusanT Description and Business Overview
11.14.3 ImmusanT Sales, Revenue and Gross Margin (2015-2020)
11.14.4 ImmusanT Products Offered
11.14.5 ImmusanT Related Developments
11.15 Innovate Biopharmaceuticals
11.15.1 Innovate Biopharmaceuticals Corporation Information
11.15.2 Innovate Biopharmaceuticals Description and Business Overview
11.15.3 Innovate Biopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Innovate Biopharmaceuticals Products Offered
11.15.5 Innovate Biopharmaceuticals Related Developments
11.16 Johnson & Johnson
11.16.1 Johnson & Johnson Corporation Information
11.16.2 Johnson & Johnson Description and Business Overview
11.16.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Johnson & Johnson Products Offered
11.16.5 Johnson & Johnson Related Developments
11.17 Kedrion Biopharma
11.17.1 Kedrion Biopharma Corporation Information
11.17.2 Kedrion Biopharma Description and Business Overview
11.17.3 Kedrion Biopharma Sales, Revenue and Gross Margin (2015-2020)
11.17.4 Kedrion Biopharma Products Offered
11.17.5 Kedrion Biopharma Related Developments
11.18 LFB Group
11.18.1 LFB Group Corporation Information
11.18.2 LFB Group Description and Business Overview
11.18.3 LFB Group Sales, Revenue and Gross Margin (2015-2020)
11.18.4 LFB Group Products Offered
11.18.5 LFB Group Related Developments
11.19 Merck
11.19.1 Merck Corporation Information
11.19.2 Merck Description and Business Overview
11.19.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.19.4 Merck Products Offered
11.19.5 Merck Related Developments
11.20 Novartis
11.20.1 Novartis Corporation Information
11.20.2 Novartis Description and Business Overview
11.20.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.20.4 Novartis Products Offered
11.20.5 Novartis Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Celiac Drugs Market Estimates and Projections by Region
12.1.1 Global Celiac Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Celiac Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Celiac Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Celiac Drugs Sales Forecast (2021-2026)
12.2.2 North America: Celiac Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Celiac Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Celiac Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Celiac Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Celiac Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Celiac Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Celiac Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Celiac Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Celiac Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Celiac Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Celiac Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Celiac Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Celiac Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Celiac Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Celiac Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Celiac Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Celiac Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Celiac Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Celiac Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Celiac Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Celiac Drugs Market Segments
Table 2. Ranking of Global Top Celiac Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Celiac Drugs Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of First Line Of Treatment
Table 5. Major Manufacturers of Second Line Of Treatment
Table 6. Global Celiac Drugs Market Size Growth Rate by Application 2020-2026 (K MT)
Table 7. Global Celiac Drugs Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 8. Global Celiac Drugs Sales by Regions 2015-2020 (K MT)
Table 9. Global Celiac Drugs Sales Market Share by Regions (2015-2020)
Table 10. Global Celiac Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Celiac Drugs Sales by Manufacturers (2015-2020) (K MT)
Table 12. Global Celiac Drugs Sales Share by Manufacturers (2015-2020)
Table 13. Global Celiac Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Celiac Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Celiac Drugs as of 2019)
Table 15. Celiac Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Celiac Drugs Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Celiac Drugs Price (2015-2020) (USD/MT)
Table 18. Celiac Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Celiac Drugs Product Type
Table 20. Date of International Manufacturers Enter into Celiac Drugs Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Celiac Drugs Sales by Type (2015-2020) (K MT)
Table 23. Global Celiac Drugs Sales Share by Type (2015-2020)
Table 24. Global Celiac Drugs Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Celiac Drugs Revenue Share by Type (2015-2020)
Table 26. Celiac Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 27. Global Celiac Drugs Sales by Application (2015-2020) (K MT)
Table 28. Global Celiac Drugs Sales Share by Application (2015-2020)
Table 29. North America Celiac Drugs Sales by Country (2015-2020) (K MT)
Table 30. North America Celiac Drugs Sales Market Share by Country (2015-2020)
Table 31. North America Celiac Drugs Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Celiac Drugs Revenue Market Share by Country (2015-2020)
Table 33. North America Celiac Drugs Sales by Type (2015-2020) (K MT)
Table 34. North America Celiac Drugs Sales Market Share by Type (2015-2020)
Table 35. North America Celiac Drugs Sales by Application (2015-2020) (K MT)
Table 36. North America Celiac Drugs Sales Market Share by Application (2015-2020)
Table 37. Europe Celiac Drugs Sales by Country (2015-2020) (K MT)
Table 38. Europe Celiac Drugs Sales Market Share by Country (2015-2020)
Table 39. Europe Celiac Drugs Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Celiac Drugs Revenue Market Share by Country (2015-2020)
Table 41. Europe Celiac Drugs Sales by Type (2015-2020) (K MT)
Table 42. Europe Celiac Drugs Sales Market Share by Type (2015-2020)
Table 43. Europe Celiac Drugs Sales by Application (2015-2020) (K MT)
Table 44. Europe Celiac Drugs Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Celiac Drugs Sales by Region (2015-2020) (K MT)
Table 46. Asia Pacific Celiac Drugs Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Celiac Drugs Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Celiac Drugs Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Celiac Drugs Sales by Type (2015-2020) (K MT)
Table 50. Asia Pacific Celiac Drugs Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Celiac Drugs Sales by Application (2015-2020) (K MT)
Table 52. Asia Pacific Celiac Drugs Sales Market Share by Application (2015-2020)
Table 53. Latin America Celiac Drugs Sales by Country (2015-2020) (K MT)
Table 54. Latin America Celiac Drugs Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Celiac Drugs Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Celiac Drugs Revenue Market Share by Country (2015-2020)
Table 57. Latin America Celiac Drugs Sales by Type (2015-2020) (K MT)
Table 58. Latin America Celiac Drugs Sales Market Share by Type (2015-2020)
Table 59. Latin America Celiac Drugs Sales by Application (2015-2020) (K MT)
Table 60. Latin America Celiac Drugs Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Celiac Drugs Sales by Country (2015-2020) (K MT)
Table 62. Middle East and Africa Celiac Drugs Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Celiac Drugs Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Celiac Drugs Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Celiac Drugs Sales by Type (2015-2020) (K MT)
Table 66. Middle East and Africa Celiac Drugs Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Celiac Drugs Sales by Application (2015-2020) (K MT)
Table 68. Middle East and Africa Celiac Drugs Sales Market Share by Application (2015-2020)
Table 69. ADMA Biologics Corporation Information
Table 70. ADMA Biologics Description and Major Businesses
Table 71. ADMA Biologics Celiac Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 72. ADMA Biologics Product
Table 73. ADMA Biologics Recent Development
Table 74. Amgen Corporation Information
Table 75. Amgen Description and Major Businesses
Table 76. Amgen Celiac Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Amgen Product
Table 78. Amgen Recent Development
Table 79. Anthera Pharmaceuticals Corporation Information
Table 80. Anthera Pharmaceuticals Description and Major Businesses
Table 81. Anthera Pharmaceuticals Celiac Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Anthera Pharmaceuticals Product
Table 83. Anthera Pharmaceuticals Recent Development
Table 84. Bayer Corporation Information
Table 85. Bayer Description and Major Businesses
Table 86. Bayer Celiac Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Bayer Product
Table 88. Bayer Recent Development
Table 89. Biogen Corporation Information
Table 90. Biogen Description and Major Businesses
Table 91. Biogen Celiac Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 92. Biogen Product
Table 93. Biogen Recent Development
Table 94. BioLineRx Corporation Information
Table 95. BioLineRx Description and Major Businesses
Table 96. BioLineRx Celiac Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 97. BioLineRx Product
Table 98. BioLineRx Recent Development
Table 99. Biotest Corporation Information
Table 100. Biotest Description and Major Businesses
Table 101. Biotest Celiac Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 102. Biotest Product
Table 103. Biotest Recent Development
Table 104. Bristol-Myers Squibb Corporation Information
Table 105. Bristol-Myers Squibb Description and Major Businesses
Table 106. Bristol-Myers Squibb Celiac Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 107. Bristol-Myers Squibb Product
Table 108. Bristol-Myers Squibb Recent Development
Table 109. Celgene Corporation Information
Table 110. Celgene Description and Major Businesses
Table 111. Celgene Celiac Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Celgene Product
Table 113. Celgene Recent Development
Table 114. Celimmune Corporation Information
Table 115. Celimmune Description and Major Businesses
Table 116. Celimmune Celiac Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Celimmune Product
Table 118. Celimmune Recent Development
Table 119. F Hoffmann-La Roche Corporation Information
Table 120. F Hoffmann-La Roche Description and Major Businesses
Table 121. F Hoffmann-La Roche Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 122. F Hoffmann-La Roche Product
Table 123. F Hoffmann-La Roche Recent Development
Table 124. ImmunogenX Corporation Information
Table 125. ImmunogenX Description and Major Businesses
Table 126. ImmunogenX Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 127. ImmunogenX Product
Table 128. ImmunogenX Recent Development
Table 129. Immunomedics Corporation Information
Table 130. Immunomedics Description and Major Businesses
Table 131. Immunomedics Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 132. Immunomedics Product
Table 133. Immunomedics Recent Development
Table 134. ImmusanT Corporation Information
Table 135. ImmusanT Description and Major Businesses
Table 136. ImmusanT Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 137. ImmusanT Product
Table 138. ImmusanT Recent Development
Table 139. Innovate Biopharmaceuticals Corporation Information
Table 140. Innovate Biopharmaceuticals Description and Major Businesses
Table 141. Innovate Biopharmaceuticals Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 142. Innovate Biopharmaceuticals Product
Table 143. Innovate Biopharmaceuticals Recent Development
Table 144. Johnson & Johnson Corporation Information
Table 145. Johnson & Johnson Description and Major Businesses
Table 146. Johnson & Johnson Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 147. Johnson & Johnson Product
Table 148. Johnson & Johnson Recent Development
Table 149. Kedrion Biopharma Corporation Information
Table 150. Kedrion Biopharma Description and Major Businesses
Table 151. Kedrion Biopharma Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 152. Kedrion Biopharma Product
Table 153. Kedrion Biopharma Recent Development
Table 154. LFB Group Corporation Information
Table 155. LFB Group Description and Major Businesses
Table 156. LFB Group Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 157. LFB Group Product
Table 158. LFB Group Recent Development
Table 159. Merck Corporation Information
Table 160. Merck Description and Major Businesses
Table 161. Merck Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 162. Merck Product
Table 163. Merck Recent Development
Table 164. Novartis Corporation Information
Table 165. Novartis Description and Major Businesses
Table 166. Novartis Celiac Drugs Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 167. Novartis Product
Table 168. Novartis Recent Development
Table 169. Global Celiac Drugs Sales Forecast by Regions (2021-2026) (K MT)
Table 170. Global Celiac Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 171. Global Celiac Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 172. Global Celiac Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 173. North America: Celiac Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 174. North America: Celiac Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 175. Europe: Celiac Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 176. Europe: Celiac Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 177. Asia Pacific: Celiac Drugs Sales Forecast by Region (2021-2026) (K MT)
Table 178. Asia Pacific: Celiac Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 179. Latin America: Celiac Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 180. Latin America: Celiac Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 181. Middle East and Africa: Celiac Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 182. Middle East and Africa: Celiac Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 183. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 184. Key Challenges
Table 185. Market Risks
Table 186. Main Points Interviewed from Key Celiac Drugs Players
Table 187. Celiac Drugs Customers List
Table 188. Celiac Drugs Distributors List
Table 189. Research Programs/Design for This Report
Table 190. Key Data Information from Secondary Sources
Table 191. Key Data Information from Primary Sources
List of Figures
Figure 1. Celiac Drugs Product Picture
Figure 2. Global Celiac Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. First Line Of Treatment Product Picture
Figure 4. Second Line Of Treatment Product Picture
Figure 5. Global Celiac Drugs Sales Market Share by Application in 2020 & 2026
Figure 6. Men
Figure 7. Women
Figure 8. Children
Figure 9. Celiac Drugs Report Years Considered
Figure 10. Global Celiac Drugs Market Size 2015-2026 (US$ Million)
Figure 11. Global Celiac Drugs Sales 2015-2026 (K MT)
Figure 12. Global Celiac Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Celiac Drugs Sales Market Share by Region (2015-2020)
Figure 14. Global Celiac Drugs Sales Market Share by Region in 2019
Figure 15. Global Celiac Drugs Revenue Market Share by Region (2015-2020)
Figure 16. Global Celiac Drugs Revenue Market Share by Region in 2019
Figure 17. Global Celiac Drugs Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Celiac Drugs Revenue in 2019
Figure 19. Celiac Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Celiac Drugs Sales Market Share by Type (2015-2020)
Figure 21. Global Celiac Drugs Sales Market Share by Type in 2019
Figure 22. Global Celiac Drugs Revenue Market Share by Type (2015-2020)
Figure 23. Global Celiac Drugs Revenue Market Share by Type in 2019
Figure 24. Global Celiac Drugs Market Share by Price Range (2015-2020)
Figure 25. Global Celiac Drugs Sales Market Share by Application (2015-2020)
Figure 26. Global Celiac Drugs Sales Market Share by Application in 2019
Figure 27. Global Celiac Drugs Revenue Market Share by Application (2015-2020)
Figure 28. Global Celiac Drugs Revenue Market Share by Application in 2019
Figure 29. North America Celiac Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 30. North America Celiac Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Celiac Drugs Sales Market Share by Country in 2019
Figure 32. North America Celiac Drugs Revenue Market Share by Country in 2019
Figure 33. U.S. Celiac Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 34. U.S. Celiac Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Celiac Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 36. Canada Celiac Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Celiac Drugs Market Share by Type in 2019
Figure 38. North America Celiac Drugs Market Share by Application in 2019
Figure 39. Europe Celiac Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 40. Europe Celiac Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Celiac Drugs Sales Market Share by Country in 2019
Figure 42. Europe Celiac Drugs Revenue Market Share by Country in 2019
Figure 43. Germany Celiac Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 44. Germany Celiac Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Celiac Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 46. France Celiac Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Celiac Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 48. U.K. Celiac Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Celiac Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 50. Italy Celiac Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Celiac Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 52. Russia Celiac Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Celiac Drugs Market Share by Type in 2019
Figure 54. Europe Celiac Drugs Market Share by Application in 2019
Figure 55. Asia Pacific Celiac Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 56. Asia Pacific Celiac Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Celiac Drugs Sales Market Share by Region in 2019
Figure 58. Asia Pacific Celiac Drugs Revenue Market Share by Region in 2019
Figure 59. China Celiac Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 60. China Celiac Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Celiac Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 62. Japan Celiac Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Celiac Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 64. South Korea Celiac Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Celiac Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 66. India Celiac Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Celiac Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 68. Australia Celiac Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Celiac Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 70. Taiwan Celiac Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Celiac Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 72. Indonesia Celiac Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Celiac Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 74. Thailand Celiac Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Celiac Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 76. Malaysia Celiac Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Celiac Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 78. Philippines Celiac Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Celiac Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 80. Vietnam Celiac Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Celiac Drugs Market Share by Type in 2019
Figure 82. Asia Pacific Celiac Drugs Market Share by Application in 2019
Figure 83. Latin America Celiac Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 84. Latin America Celiac Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Celiac Drugs Sales Market Share by Country in 2019
Figure 86. Latin America Celiac Drugs Revenue Market Share by Country in 2019
Figure 87. Mexico Celiac Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 88. Mexico Celiac Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Celiac Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 90. Brazil Celiac Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Celiac Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 92. Argentina Celiac Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Celiac Drugs Market Share by Type in 2019
Figure 94. Latin America Celiac Drugs Market Share by Application in 2019
Figure 95. Middle East and Africa Celiac Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 96. Middle East and Africa Celiac Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Celiac Drugs Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Celiac Drugs Revenue Market Share by Country in 2019
Figure 99. Turkey Celiac Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 100. Turkey Celiac Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Celiac Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 102. Saudi Arabia Celiac Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Celiac Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 104. U.A.E Celiac Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Celiac Drugs Market Share by Type in 2019
Figure 106. Middle East and Africa Celiac Drugs Market Share by Application in 2019
Figure 107. North America Celiac Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 108. North America Celiac Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Celiac Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 110. Europe Celiac Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Celiac Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 112. Asia Pacific Celiac Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Celiac Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 114. Latin America Celiac Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Celiac Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. Middle East and Africa Celiac Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed
セリアック病の世界市場（～2026年） Market Analysis and Insights: Global Celiac Disease Market The global Celiac Disease market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Celiac Disease Scope and Market Size Celiac Disease market is segmented by Type, and …- セリアック病治療薬の世界市場（～2026年） Market Analysis and Insights: Global Celiac Disease Drug Market The global Celiac Disease Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Celiac Disease Drug Scope and Market Size Celiac Disease Drug market is seg…
- 白血病治療薬の世界市場（～2026年） Leukemia Treatment Drugs is used to cure Leukemia. Increasing geriatric population base and high unmet needs regarding early diagnosis and treatment of leukemia are the key factors driving the leukemia therapeutics market. Market Analysis and Insights: Global Leukemia Treatment Drugs Market The glob…
- ドライアイ治療薬・装置治療の世界市場（～2026年） Dry eye disease is a condition that affects the tear film and ocular surface. It is medically known as keratoconjunctivitis sicca. It is an ocular disorder caused by the lack of tear fluid to lubricate the eyes. There are primarily two types of dry eye conditions. One is aqueous tear-deficient dry e…
- 喘息治療薬の世界市場（～2026年） Market Analysis and Insights: Global Asthma Treatment Drugs Market The global Asthma Treatment Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Asthma Treatment Drugs Scope and Market Size Asthma Treatment Drugs m…